XBIO logo
XBIO NASDAQ US

Xenetic Biosciences, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2016
$3.01
▲ +$0.19 (+6.74%)
Vol 12K
5
Quality Score
fail
Mkt Cap
$5.0M
ROE
-64.6%
Margin
-110.4%
D/E
0.00
Beta
2.31
52W
$2–$14

Wall Street Consensus

6 analysts · Feb 2026
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

PMCB
PharmaCyte Biotech Inc
$7.3M
SYBX
Synlogic Inc
$13.1M
LIMN
Liminatus Pharma Inc
$16.5M
TCRT
Alaunos Therapeutics Inc
$7.2M
CDIO
Cardio Diagnostics Holdings Inc
$4.9M
BRTX
BioRestorative Therapies Inc
$10.4M
ERNA
Ernexa Therapeutics Inc
$9.4M
ENSC
Ensysce Biosciences Inc
$3.3M

Earnings

Beat rate: 50.0%
Next Report May 11, 2026
Quarter EPS Est EPS Act Surprise
Mar 2026 — — —
Jun 2025 $-0.65 $-0.45 +$0.20
Mar 2025 $-0.73 $-0.59 +$0.14
Dec 2024 $-0.20 $-0.68 $-0.48

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -54.5% -57.3% -54.5% -54.5% -54.5% -64.6%
P/E (TTM) — — — — — —
Net Margin -116.8% -142.0% -126.0% -126.0% -126.0% -110.4%
Gross Margin — 98.7% 98.7% 98.7% 98.7% 98.7%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 5.93 8.20 5.93 5.93 5.93 4.56

Key Ratios

ROA (TTM)
-54.6%
P/S (TTM)
1.74
P/B
1.0
EPS (TTM)
$-2.05
CF/Share
$-2.92
Rev Growth 3Y
+29.2%
52W High
$13.93
52W Low
$1.90
$1.90 52-Week Range $13.93

How does XBIO compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

XBIO AAPG ABEO ABOS ABP

XBIO valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
1.7
▼ 86% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.0
▼ 58% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

XBIO profitability vs Biotechnology peers

ROE
-64.6%
▲ 4% above peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-110.4%
▲ 61% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
98.7%
▲ 26% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-54.6%
▼ 17% below peers (-46.7%)
vs Peers
vs Industry
Below avg

XBIO financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.6
▲ 3% above peers (4.4)
vs Peers
vs Industry
In line
Beta
2.3
▲ 138% above peers (1.0)
vs Peers
vs Industry
More volatile

XBIO fundamentals radar

XBIO Peer median Industry

XBIO profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

XBIO vs peers: key metrics

Latest News

No related news yet